FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Rx-to-OTC Switch List

January 1 through June 1, 2008

There are no switches for this period of time.

January 1 through December 31, 2007

NDA Drug Name Purpose Approval Date
NDA 21-887 Orlistat Weight Loss Aid 2-7-2007
NDA 21-150/S-007 Zyrtec-D Antihistamine and Nasal Decongestant 11-9-2007
NDA 22-155 Children’s Zyrtec Allergy and Children’s Zyrtec Hives Relief (syrup) Antihistamine 11-16-2007
NDA 21-621/S-005 Children’s Zyrtec Allergy and Children’s Zyrtec Hives Relief (chewable tablets) Antihistamine 11-16-2007
NDA 19-835/S-022 Zyrtec Allergy and Zyrtec Hives Relief (tablets) Antihistamine 11-16-2007

January 1 through December 31, 2006

NDA Drug Name Purpose Approval Date
NDA 21-958 Lamisil Derm Gel Topical Antifungal 7-24-2006
NDA 21-045 Plan B Emergency Contraceptive 8-24-2006
NDA 22-015 MiraLax Laxative 10-6-2006
NDA 21-066 Zaditor Antihistamine Eye Drop 10-19-2006
NDA 21-698 Zantac 150 Acid reducer 8-21-2004

January 1 through December 31, 2004

NDA Drug Name Purpose Approval Date
NDA 21-6201 Mucinex DM ER Tablet Expectorant/Cough Suppressant 4-29-2004
NDA 21-5851 Mucinex D ER Tablet Expectorant/Decongestant 6-22-2004
NDA 21-698 Zantac 150 Acid reducer 8-21-2004

January 1 through December 31, 2003

NDA Drug Name Purpose Approval Date
NDA 21-229 Prilosec OTC Acid reducer/PPI 6-20-2003
NDA 20-325/S-015 Pepcid AC Maximum Strength Acid Reducer/H2 blocker 9-23-2003
NDA 19-658 Claritin Tablets Antihistamine 11-19-2003

January 1 through December 31, 2002

NDA Drug Name Purpose Approval Date
NDA 20-150 Nicotrol TD Smoking Cessation 3-21-2002
NDA 21-2821 Mucinex ER Tablet Expectoran 7-12-2002
NDA 20-641 Claritin Syrup Antihistamine 11-27-2002
NDA 20-704 Claritin Reditabs Antihistamine 11-27-2002
NDA 19-670 Claritin-D Antihistamine/Decongestant 11-27-2002
NDA 20-470 Claritin-D 24-hour Antihistamine/Decongestant 11-27-2002

January 1 through December 31, 2001

NDA Drug Name Purpose Approval Date
NDA 21-261 Monistat 3 combo pk Vaginal Antifungal 2-2-2001
NDA 21-308 Monistat 1 (supp) Vaginal Antifungal 6-29-2001
NDA 21-307 Lotrimin Ultra Topical Antifungal 12-07-2001

1These NDAs are not true switches because these products were marketed as prescription products without an approved NDA prior to being approved for OTC marketing under an NDA.

to top arrow Back to Top     back arrow Back to ONP Industry

Date created: July 2, 2008

horizonal rule